Back to search

Article

Effectiveness of Rimegepant in Vestibular Migraine: A Prospective Self-controlled Cohort Study

2025-11-14

Abstract excerpt

<title>Abstract</title> <p>Background Vestibular migraine (VM) is the second most common cause of episodic vertigo worldwide, yet effective therapeutic options remain limited. This study aimed to assess the clinical effectiveness of rimegepant in patients with VM. Methods A total of 33 VM cases were enrolled in this multicenter, prospective self-controlled cohort study, screened from an initial pool of 106 patien...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
14cadfaf-1388-5102-92bc-814d48387b30
DOI
10.21203/rs.3.rs-8009385/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effectiveness of Rimegepant in Vestibular Migraine: A Prospective Self-controlled Cohort StudyDOI 10.21203/rs.3.rs-8009385/v1
Select a neighboring publication to make it the new centre.